Home›Search›Blood Neoplasia

Blood Neoplasia

Elsevier · United States

eISSN2950-3280

SJR Q1✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Scopus Q178

✓ Corroboration (2 more)+12

Total90

Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 25% in field

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

SJR Scorei

1.181

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

Aims & Scope✦ Inferred from recent articles

Blood Neoplasia focuses on hematologic malignancies, including leukemias and lymphomas. Research covers therapeutic strategies such as targeted therapies (e.g., Menin inhibitors, B-cell lymphoma 2 inhibitors), immunotherapy (e.g., CAR T-cell therapy, PD-1 inhibitors), and novel drug combinations. The journal also investigates biomarkers like circulating tumor DNA (ctDNA) for disease monitoring and prognostic assessment, and explores the molecular pathogenesis of these cancers, including genomic alterations and resistance mechanisms.

AI-summarised from recent articles · verify on publisher page →

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published—

StatusActive

Total Publications—

Visit Journal Website

Submission Info

APC Cost$3,000Above median

Peer ReviewAnonymous peer review

Review Time—

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

9/12 · 75%

✅

Do you know the journal / publisher?

Elsevier

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2950-3280

✅

Indexed in a trusted database?

Scopus, DOAJ, PubMed

✅

Peer review process documented?

Anonymous peer review

❌

Follows ethical publishing standards (COPE)?

N/A

✅

APC fees clearly disclosed?

$3,000

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

HematologyQ1

OncologyQ2

Subject Classification

Research Topics (OpenAlex)

Acute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia TreatmentsMultiple Myeloma Research and TreatmentsAcute Lymphoblastic Leukemia researchCAR-T cell therapy researchMyeloproliferative Neoplasms: Diagnosis and TreatmentProtein Degradation and InhibitorsRetinoids in leukemia and cellular processes

Frequently asked questions about Blood Neoplasia

Is Blood Neoplasia a predatory journal?

PubScope has no integrity flags on record for Blood Neoplasia: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 90/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Blood Neoplasia?

Blood Neoplasia is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 1.181.

Is Blood Neoplasia indexed in Scopus and Web of Science?

Blood Neoplasia is indexed in Scopus, DOAJ.

How much does it cost to publish in Blood Neoplasia?

Blood Neoplasia charges an article processing charge (APC) of about $3,000 for open-access publication.